Liao Xiaolin, Han Yuanshan, He Ying, Liu Jianjun, Wang Yuhong
Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Scientific Research Department, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Front Pharmacol. 2023 Jun 15;14:1209890. doi: 10.3389/fphar.2023.1209890. eCollection 2023.
Hypertension generally causes target organ damage (TOD) in the heart, brain, kidney, and blood vessels. This can result in atherosclerosis, plaque formation, cardiovascular and cerebrovascular events, and renal failure. Recent studies have indicated that mitochondrial dysfunction is crucial in hypertensive target organ damage. Consequently, mitochondria-targeted therapies attract increasing attention. Natural compounds are valuable resources for drug discovery and development. Many studies have demonstrated that natural compounds can ameliorate mitochondrial dysfunction in hypertensive target organ damage. This review examines the contribution of mitochondrial dysfunction to the development of target organ damage in hypertension. Moreover, it summarizes therapeutic strategies based on natural compounds that target mitochondrial dysfunction, which may be beneficial for preventing and treating hypertensive target organ damage.
高血压通常会导致心脏、大脑、肾脏和血管的靶器官损伤(TOD)。这可能会引发动脉粥样硬化、斑块形成、心脑血管事件以及肾衰竭。最近的研究表明,线粒体功能障碍在高血压靶器官损伤中起着关键作用。因此,针对线粒体的治疗方法越来越受到关注。天然化合物是药物发现和开发的宝贵资源。许多研究表明,天然化合物可以改善高血压靶器官损伤中的线粒体功能障碍。本综述探讨了线粒体功能障碍在高血压靶器官损伤发展中的作用。此外,它总结了基于针对线粒体功能障碍的天然化合物的治疗策略,这可能有助于预防和治疗高血压靶器官损伤。